Ovarian cancer

Kathleen R. Cho, Ie Ming Shih

Research output: Contribution to journalArticle

Abstract

Ovarian carcinomas are a heterogeneous group of neoplasms and are traditionally subclassified based on type and degree of differentiation. Although current clinical management of ovarian carcinoma largely fails to take this heterogeneity into account, it is becoming evident that each major histological type has characteristic genetic defects that deregulate specific signaling pathways in the tumor cells. Moreover, within the most common histological types, the molecular pathogenesis of low-grade versus high-grade tumors appears to be largely distinct. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene-expression patterns of selected subtypes of ovarian cancer. Such models will likely prove useful for studying ovarian cancer biology and for preclinical testing of molecularly targeted therapeutics, which may ultimately lead to better clinical outcomes for women with ovarian cancer.

Original languageEnglish (US)
Pages (from-to)287-313
Number of pages27
JournalAnnual Review of Pathology: Mechanisms of Disease
Volume4
DOIs
StatePublished - Feb 2009

Fingerprint

ovarian neoplasms
Ovarian Neoplasms
carcinoma
Carcinoma
Neoplasms
neoplasms
genetic disorders
pathogenesis
animal models
Gene Expression
Biological Sciences
gene expression
therapeutics
testing
Therapeutics

Keywords

  • Classification
  • Endometrioid
  • Genetics
  • Mouse models
  • Serous

ASJC Scopus subject areas

  • Plant Science
  • Medicine(all)

Cite this

Ovarian cancer. / Cho, Kathleen R.; Shih, Ie Ming.

In: Annual Review of Pathology: Mechanisms of Disease, Vol. 4, 02.2009, p. 287-313.

Research output: Contribution to journalArticle

Cho, Kathleen R. ; Shih, Ie Ming. / Ovarian cancer. In: Annual Review of Pathology: Mechanisms of Disease. 2009 ; Vol. 4. pp. 287-313.
@article{0ffc5fa4a13f4932ada77f65634affdc,
title = "Ovarian cancer",
abstract = "Ovarian carcinomas are a heterogeneous group of neoplasms and are traditionally subclassified based on type and degree of differentiation. Although current clinical management of ovarian carcinoma largely fails to take this heterogeneity into account, it is becoming evident that each major histological type has characteristic genetic defects that deregulate specific signaling pathways in the tumor cells. Moreover, within the most common histological types, the molecular pathogenesis of low-grade versus high-grade tumors appears to be largely distinct. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene-expression patterns of selected subtypes of ovarian cancer. Such models will likely prove useful for studying ovarian cancer biology and for preclinical testing of molecularly targeted therapeutics, which may ultimately lead to better clinical outcomes for women with ovarian cancer.",
keywords = "Classification, Endometrioid, Genetics, Mouse models, Serous",
author = "Cho, {Kathleen R.} and Shih, {Ie Ming}",
year = "2009",
month = "2",
doi = "10.1146/annurev.pathol.4.110807.092246",
language = "English (US)",
volume = "4",
pages = "287--313",
journal = "Annual Review of Pathology: Mechanisms of Disease",
issn = "1553-4006",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Ovarian cancer

AU - Cho, Kathleen R.

AU - Shih, Ie Ming

PY - 2009/2

Y1 - 2009/2

N2 - Ovarian carcinomas are a heterogeneous group of neoplasms and are traditionally subclassified based on type and degree of differentiation. Although current clinical management of ovarian carcinoma largely fails to take this heterogeneity into account, it is becoming evident that each major histological type has characteristic genetic defects that deregulate specific signaling pathways in the tumor cells. Moreover, within the most common histological types, the molecular pathogenesis of low-grade versus high-grade tumors appears to be largely distinct. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene-expression patterns of selected subtypes of ovarian cancer. Such models will likely prove useful for studying ovarian cancer biology and for preclinical testing of molecularly targeted therapeutics, which may ultimately lead to better clinical outcomes for women with ovarian cancer.

AB - Ovarian carcinomas are a heterogeneous group of neoplasms and are traditionally subclassified based on type and degree of differentiation. Although current clinical management of ovarian carcinoma largely fails to take this heterogeneity into account, it is becoming evident that each major histological type has characteristic genetic defects that deregulate specific signaling pathways in the tumor cells. Moreover, within the most common histological types, the molecular pathogenesis of low-grade versus high-grade tumors appears to be largely distinct. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene-expression patterns of selected subtypes of ovarian cancer. Such models will likely prove useful for studying ovarian cancer biology and for preclinical testing of molecularly targeted therapeutics, which may ultimately lead to better clinical outcomes for women with ovarian cancer.

KW - Classification

KW - Endometrioid

KW - Genetics

KW - Mouse models

KW - Serous

UR - http://www.scopus.com/inward/record.url?scp=66149083645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149083645&partnerID=8YFLogxK

U2 - 10.1146/annurev.pathol.4.110807.092246

DO - 10.1146/annurev.pathol.4.110807.092246

M3 - Article

VL - 4

SP - 287

EP - 313

JO - Annual Review of Pathology: Mechanisms of Disease

JF - Annual Review of Pathology: Mechanisms of Disease

SN - 1553-4006

ER -